Cited by 3,811Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and TreatmentsAcute Ischemic Stroke Management

The DOI matches its Crossref record; 526 of the 538 references it cites were found in a registry or an index; 137 of the 627 sources its claims cite were checked for support.

Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

Open access

Abstract

Background and Purpose—: This scientific statement provides an overview of the evidence on vascular contributions to cognitive impairment and dementia. Vascular contributions to cognitive impairment and dementia of later life are common. Definitions of vascular cognitive impairment (VCI), neuropathology, basic science and pathophysiological aspects, role of neuroimaging and vascular and other associated risk factors, and potential opportunities for prevention and treatment are reviewed. This statement serves as an overall guide for practitioners to gain a better understanding of VCI and dementia, prevention, and treatment. Methods—: Writing group members were nominated by the writing group co-chairs on the basis of their previous work in relevant topic areas and were approved by the American Heart Association Stroke Council Scientific Statement Oversight Committee, the Council on Epidemiology and Prevention, and the Manuscript Oversight Committee. The writing group used systematic literature reviews (primarily covering publications from 1990 to May 1, 2010), previously published guidelines, personal files, and expert opinion to summarize existing evidence, indicate gaps in current knowledge, and, when appropriate, formulate recommendations using standard American Heart Association criteria. All members of the writing group had the opportunity to comment on the recommendations and approved the final version of this document. After peer review by the American Heart Association, as well as review by the Stroke Council leadership, Council on Epidemiology and Prevention Council, and Scientific Statements Oversight Committee, the statement was approved by the American Heart Association Science Advisory and Coordinating Committee. Results—: The construct of VCI has been introduced to capture the entire spectrum of cognitive disorders associated with all forms of cerebral vascular brain injury—not solely stroke—ranging from mild cognitive impairment through fully developed dementia. Dysfunction of the neurovascular unit and mechanisms regulating cerebral blood flow are likely to be important components of the pathophysiological processes underlying VCI. Cerebral amyloid angiopathy is emerging as an important marker of risk for Alzheimer disease, microinfarction, microhemorrhage and macrohemorrhage of the brain, and VCI. The neuropathology of cognitive impairment in later life is often a mixture of Alzheimer disease and microvascular brain damage, which may overlap and synergize to heighten the risk of cognitive impairment. In this regard, magnetic resonance imaging and other neuroimaging techniques play an important role in the definition and detection of VCI and provide evidence that subcortical forms of VCI with white matter hyperintensities and small deep infarcts are common. In many cases, risk markers for VCI are the same as traditional risk factors for stroke. These risks may include but are not limited to atrial fibrillation, hypertension, diabetes mellitus, and hypercholesterolemia. Furthermore, these same vascular risk factors may be risk markers for Alzheimer disease. Carotid intimal-medial thickness and arterial stiffness are emerging as markers of arterial aging and may serve as risk markers for VCI. Currently, no specific treatments for VCI have been approved by the US Food and Drug Administration. However, detection and control of the traditional risk factors for stroke and cardiovascular disease may be effective in the prevention of VCI, even in older people. Conclusions—: Vascular contributions to cognitive impairment and dementia are important. Understanding of VCI has evolved substantially in recent years, based on preclinical, neuropathologic, neuroimaging, physiological, and epidemiological studies. Transdisciplinary, translational, and transactional approaches are recommended to further our understanding of this entity and to better characterize its neuropsychological profile. There is a need for prospective, quantitative, clinical-pathological-neuroimaging studies to improve knowledge of the pathological basis of neuroimaging change and the complex interplay between vascular and Alzheimer disease pathologies in the evolution of clinical VCI and Alzheimer disease. Long-term vascular risk marker interventional studies beginning as early as midlife may be required to prevent or postpone the onset of VCI and Alzheimer disease. Studies of intensive reduction of vascular risk factors in high-risk groups are another important avenue of research.

Overview

Integrity signals

Registry

Crossref · 10.1161/str.0b013e3182299496

Cites

526 of 526 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

137 of 627 cited sources checked · 45 supported · 6 flagged · accuracy not yet measured

Show all 316 claims

  • It may state two separate claims as one. 168
  • Probably not a substantial claim. 47
205 of 205
  • The authors state this as an assumption.

    The underlying neuropathological substrate of amnestic mild cognitive impairment is pure Alzheimer disease pathology rather than vascular or mixed pathology.

    “assuming the underlying neuropathological substrate of amnestic MCI is pure Alzheimer disease pathology rather than vascular or mixed pathology”
  • The paper relies on this without support.

    Neuroimaging detects macroscopic infarcts about 3 mm or more in size, but microscopic infarcts and small-vessel disease are currently not within the resolution of most scans.

    “First, neuroimaging detects macroscopic infarcts, ≈3 mm or more in size, but microscopic infarcts and small-vessel disease (eg, arteriolosclerosis) are currently not within the resolution of most scans.”
  • The paper relies on this without support.

    Stiffer large arteries are associated with increased left ventricular mass.

    “Additionally, stiffer large arteries are associated with increased left ventricular mass.”
  • The paper relies on this without support.

    No study has investigated the relationship between small-artery remodeling and cognitive decline or white matter lesions.

    “To the best of our knowledge, no study has investigated the relationship between small-artery remodeling and cognitive decline or WMLs.”
  • The paper relies on this without support.

    In community-based studies, evidence of CVBI and cognitive impairment is often found without a history of a strokelike event.

    “For example, in community-based studies, evidence of CVBI and cognitive impairment is often found without a history of a strokelike event.”
  • The paper relies on this without support.

    Late-life depression may be accompanied by a higher frequency of brain white matter damage and other subcortical lesions, such as lacunar infarcts.

    “There may be a higher frequency of brain white matter damage and other subcortical lesions, such as lacunar infarcts.”
  • The paper relies on this without support.

    Depression with a cerebrovascular basis may respond to treatment with certain selective serotonin-reuptake inhibitors.

    “Depression with a cerebrovascular basis may respond to treatment with certain selective serotonin-reuptake inhibitors.”
  • The paper relies on this without support.

    The activity of biomarkers in the brain generally cannot be measured directly.

    “The activity of biomarkers in the brain generally cannot be measured directly.”
  • The paper relies on this without support.

    The only clear risk for cognitive impairment from alcohol intake is heavy alcohol use.

    “The risks and benefits of alcohol intake have been debated for years, with the only clear risk for cognitive impairment being heavy alcohol use.”
  • The paper relies on this without support.

    Smoking's effects on the cardiovascular system and neurons are mediated generally by oxidative stress and inflammation.

    “Smoking has well-known effects on the cardiovascular system and neurons, which are mediated generally by oxidative stress and inflammation.”
  • The paper relies on this without support.

    Inflammation is a key process linking many cardiovascular risk factors to vascular and neuronal damage.

    “Inflammation is a key process linking many cardiovascular risk factors to vascular and neuronal damage.”
  • The paper relies on this without support.

    During midlife, the population-attributable risk of dementia is highest for hypertension, up to 30% of late-life dementia cases.

    “In relation to the role of vascular risk factors, during midlife the population-attributable risk of dementia has been reported to be highest for hypertension (up to 30% of cases of late-life dementia).”
  • The paper relies on this without support.

    Smoking is a risk factor for stroke-associated dementia.

    “Smoking is a risk factor for stroke-associated dementia.”
  • The paper relies on this without support.

    Hyperlipidemia or dyslipidemia is a metabolic condition of importance for cognitive function.

    “Hyperlipidemia or dyslipidemia is a metabolic condition of importance for cognitive function.”
  • The paper relies on this without support.

    Cognitive function is an important predictor of morbidity and mortality in the elderly.

    “Cognitive function, an important predictor of morbidity and mortality in the elderly, however, is frequently not screened for in clinical practice as part of global cardiovascular risk and target-organ damage assessments.”
  • The paper relies on this without support.

    Silent strokes outnumber clinically manifest strokes by more than nine to one.

    “It is estimated that “silent” strokes outnumber clinically manifest ones by a factor of >9:1”
  • The paper relies on this without support.

    The proportion of people with milder VCI is about twice that with severe VCI (VaD).

    “and the proportion of those with a milder form of VCI is approximately 2-fold greater than those with a severe form of VCI (ie, VaD).”
17 of 17

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Items 401–526 of 526

Flagged first, then by citations

12 of the 538 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. Geneva, Switzerland: World Health Organization; 1993.
  2. Report of the Stroke Progress Review Group. Bethesda, MD: National Institute of Neurological Disorders and Stroke; 2002.
  3. Safar M, O'Rourke MF eds. Arterial Stiffness in Hypertension: Handbook of Hypertension, Volume 23. New York, NY: Elsevier; 2006.
  4. Roose S, Sneed JR. The current status of vascular depression. US Psychiatry. 2007; 1: 21–23.

Cited by

Sorted by citations

See all 3,811

Metadata

Authors
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., Petersen, R. C., Schneider, J. A., Tzourio, C., Arnett, D. K., Bennett, D. A., Chui, H. C., Higashida, R. T., Lindquist, R., Nilsson, P. M., Roman, G. C., Sellke, F. W., & Seshadri, S.
Affiliations
Alzheimer's Association (US)
Venue
Stroke
Published
2011-09
Volume
42
Issue
9
Pages
2672-2713
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2527609605
Cited by
3,811
References
538
Citations by year
2026: 244 · 2025: 292 · 2024: 295 · 2023: 237 · 2022: 263 · 2021: 269 · 2020: 314 · 2019: 320 · 2018: 270 · 2017: 253 · 2016: 258 · 2015: 227 · 2014: 238 · 2013: 169 · 2012: 137
FWCI
23.75
Type
journal article
Language
en
Open access
Locations
  • Stroke (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
  • UnissResearch (Università degli Studi di Sassari) (submittedVersion)
Funders
  • American Heart Association
  • Bristol-Myers Squibb
  • Pfizer
  • AstraZeneca
  • GlaxoSmithKline
  • Massachusetts General Hospital
  • University of Southern California
  • University of Minnesota
  • University of Pittsburgh
  • Minneapolis Heart Institute
  • Rush University
  • Daiichi-Sankyo
  • University of Toronto
  • Eisai
  • Servier
  • H. Lundbeck A/S
  • National Institutes of Health
  • University of Illinois at Urbana-Champaign
  • Weill Cornell Medical College
  • University of California, Davis
  • National Institute on Aging (P30AG010129, R01AG021028, R01AG020098, U19AG010483)
  • National Institute of Neurological Disorders and Stroke (R01NS017950)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords
vascular cognitive impairment, dementia, mild cognitive impairment, neurovascular unit, cerebral autoregulation, cerebral amyloid angiopathy, Alzheimer's disease, white matter hyperintensities, stroke risk factors, atrial fibrillation, hypertension, diabetes mellitus, hypercholesterolemia, neuroimaging, prevention, treatment
MeSH terms
Alzheimer Disease, American Heart Association, Mental Disorders, Cerebral Angiography, Humans, Male, Risk Factors, United States, Dementia, Vascular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review